Edition:
United States

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

1.90USD
16 Feb 2018
Change (% chg)

$-0.15 (-7.32%)
Prev Close
$2.05
Open
$1.90
Day's High
$1.90
Day's Low
$1.90
Volume
1
Avg. Vol
1,925
52-wk High
$4.69
52-wk Low
$1.85

Chart for

About

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action,... (more)
No analyst recommendations are available for .

Overall

Beta: 0.10
Market Cap(Mil.): $10.08
Shares Outstanding(Mil.): 5.14
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.11 17.27
EPS (TTM): -- -- --
ROI: -- -1.15 35.43
ROE: -- -20.84 17.10

Earnings vs. Estimates